Tech Company Financing Transactions

Frequency Therapeutics Funding Round

Frequency Therapeutics closed a $42 million Series B funding round on 1/8/2019. Investors included Axil Capital, Taiwania Capital and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

19 Presidential Way
Woburn, MA 01801
USA

Phone

(781) 235-3060

Website

www.frequencytx.com

Email Address

[email protected]

Overview

Frequency Therapeutics (Nasdaq: FREQ) develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Lucchino

        

Chief Medical Officer

William Chin

        

Chief Scientific Officer

Chris Loose

        

Vice President

William Mclean

        

VP - Bus. Development

Carl Lebel

        

VP - Bus. Development

Ajay Rai

        

VP - R & D

Scott Eliasof

        

Browse more venture capital transactions:

Prev: 1/8/2019: Headset venture capital transaction
Next: 1/8/2019: Grabango venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC transactions on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary